Kyle Nelson

Mar 1, 2024 | jacc.org | Javier Sanz |Kyle Nelson

Introduction Contemporary studies have highlighted the importance of careful noninvasive assessment in patients with chronic aortic regurgitation (AR) by means of transthoracic or transesophageal echocardiogram and cardiac magnetic resonance.1 Current guidelines rely primarily on symptom assessment, left ventricular (LV) ejection fraction (<55%), and LV end-systolic diameter (>50 mm or >25 mm/m2) to inform clinicians on timing of aortic valve intervention.2 However, recent literature suggests...

Aug 13, 2023 | jacc.org | Kyle Nelson |Valentín Fuster |Paul M. Ridker

References1. "New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B: JACC focus seminar". J Am Coll Cardiol . 2021;77:1564-1575. 2. "The dawn of a new era of targeted lipid-lowering therapies". Eur Heart J . 2022;43:3198-3208. 3. "Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin". Eur Heart J . 2016;37:1720-1722. 4.